NCT05160220View on ClinicalTrials.gov

Naturalistic Study of Microdosing With Psilocybin

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

October 1, 2021

Conditions
Cognitive ChangeCreativityMood ChangeSleep
Interventions
DRUG

Psilocybin

0.5 g dried Psilocybe cubensis mushroom material, 0.8 mg psilocybin.

DRUG

Placebo

0.5 g dried edible non-psychoactive mushroom material.

Trial Locations (1)

1428

Instituto de Fisica de Buenos Aires (IFIBA), Buenos Aires

All Listed Sponsors
lead

National Council of Scientific and Technical Research, Argentina

OTHER_GOV

NCT05160220 - Naturalistic Study of Microdosing With Psilocybin | Biotech Hunter | Biotech Hunter